Venture Capital

Updated:

Hale Biopharma Ventures

Hale BioPharma Ventures is a venture investment firm founded in 2005 in Encinitas, California. It focuses on biotechnology, specialty pharmaceutical,...

Hale Biopharma Ventures

Hale BioPharma Ventures is a venture investment firm founded in 2005 in Encinitas, California. It focuses on biotechnology, specialty pharmaceutical, diagnostic, and medical device companies. The firm provides capital and strategic support to early-stage life sciences ventures.

General information

Firm type

Venture Capital

Location

Region

North America

Country

United States

Sector focus

BiotechPharmaceuticalsDigital HealthLife Sciences

Frequently asked questions

What exactly does Hale Biopharma Ventures invest in?

The firm invests in biopharmaceutical companies developing novel therapeutics. Its focus is on drug development programs rather than platform technologies or medical devices. The mandate centers on assets with clear clinical differentiation, often in oncology, rare diseases, and immunology. The firm's name emphasizes an outcome-oriented approach based on patient health.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Venture Capital profiles